text:
Currently there are no items in your shopping cart.
New By Category
Bedroom Inspiration
Update your look, get inspired with these looks for your bedroom.
Shop >
Shop by Category
Gallery Wall Guide
Use our step-by-step guide to create a curated wall of art.
Pillows & Throws
Rock On
Adorn your décor with a decorative display of natural elements.
New for Spring
Set the table with our new Coral Dinnerware and start to plan that chic spring brunch.
Sleep In
Update your bedroom with layers of luxurious bedding.
Glamorous Reflections
Use mirrors to create light and movement throughout your home.
Gifts by Occasion
Gifts by Price
Gifts by Recipient
Empty Handed?
Chic gifts for the gracious host.
Limited Time Offers
Sale By Category
By Room
Bedroom Refresh
Get inspired with chic new looks for your bedroom.
Greek Key Table Clock $49.95$24.89
Naples Sphere $24.95
Diamond Desk Set $24.95
Golden Gator Magnifier $24.95
Glass Sphere Orbit and Stand $24.95
Jellyfish Paperweight $24.95
Atlas Magnifier $24.95
Marble Box With Agate $34.95$24.99
Agate Point Paperweight $29.95
Kingston Table Clock $29.95
Dachshund Bookends $29.95
Crystal Desk Accessories $29.95
Gyration Sphere $29.95
Diamond Paperweight $29.95
Anabelle Box $29.95
Spectacle Magnifier $29.95


text:
October is breast cancer awareness month, so let us educate you and show you some ways to prevent and early detect breast cancer. This information is important for every
Mamonite Summer Sale!
Are you struggling this summer with trying to figure out whether to take that once a year vacation with your kids or spend some of your savings for yourself and
The best protection is early detection
October is breast cancer awareness month, so let us educate you and show you some ways to prevent and early detect breast cancer. This information is important for every young woman to read and think about. Did you know that with early detection and treatment, the survival rate for breast cancer climbs to more than 90%?
Some of the tips you will come across on here are common sense even though some of us still do not live up to them but some might surprise you! You have to start by eating right in order to feel right, especially by limiting your fat intake, women that followed a low-fat diet showed a modest decrease of breast cancer during research. Get moving!!! Try and attempt to exercise and don't set your goals so high because you will not achieve them, take little steps and work up. Begin your day with a 30 minute workout, and don't forget to add weight-bearing exercises, it will reduce your risk and also protect your bones. Try and maintain a healthy weight because there has been a clear link between obesity and breast cancer due to the level of excess estrogen production in fatty tissue.
Another tip you will be surprise to see is – cutting back on alcoholic drinks. During research there has been a link found between breast cancer and alcoholic drinks, limit your drink intake to one a day.
Ladies, even though you might think you are too young to think about breast cancer age does not determine when a woman finds breast cancer. Keep an eye out for breast cancer symptoms. A lump that is the size of a frozen pea that does not come and go and instead stays and grows. Constant pain on your breasts, bloody drainage from the nipple, change in breast contour (irregular shape or dimpling) at doesn't go away.
Know your body! If you notice something out of the ordinary call your OBGYN right away or your primary doctor.
Mamonite Summer Sale!
Are you struggling this summer with trying to figure out whether to take that once a year vacation with your kids or spend some of your savings for yourself and invest in natural breast enhancement pills?
If you have done your research we are one of the top natural breast enhancement companies out on the market today! Natural breast enhancement pills tend to be a money saver compare to breast enhancement surgery. In today's economy many middle class families have had to face the struggle of this economy and unfortunately have had to cut back on unneeded expenses, we as well understand. This summer we have lowered our prices to give our regular customers a chance to stock up on their favorite product. For extra specials call us today at 800 -853-8213!
Our product has been rated #1 for many years. We are mentioned and rated on www.mdbreast.com. Our product is an all natural product breast enhancer that typically gives most women results on an average of four months ( 3-6 Months). Feel your best this holiday season and give yourself a new – new years resolution and boost up your confidence with Mamonite.
You will feel young and sexy once again! Our company is one of the few that offers other products beside breast enhancement pills. Check out our website and read up on our NEW Hi-tech breast enhancer, our breast firming cream and we also feature Bella Bronze Tanning products. We have everything you need to look your best!
Ladies, our promotional holiday sale is still running until the end of the month. Buy 2 get 1 free, a three months supply for only $115.00 (BIG SAVINGS) hurry and place your order today with Express shipping to receive by Christmas!
Introducing our new product !
Mamonite is proud to bring to you the newest breast enhancer. A high-tech device that will make your breasts look firm, and fuller with a natural curve. It safe, and easy to use. This device uses a micro-computer
that electronically stimulates your breast tissue. This breast enhancer strengthens and tightens the muscles that control the look of your breasts and by using this device 5-15 minutes daily it will dramatically increase your breast size and shape. You will apply the gel to the pads and place the pads in your bra controlling the strength from the micro-computer, making this product easy to use. It will firm your breasts and soften the epidermal tissue to give you smoother breast skin. Breast Massager is powered by 2xAAA batteries (not included).
Restoring your breasts after pregnancy
If you haven't had a child yet, when thinking about having a beautiful baby us women tend to first think about what does pregnancy do to our bodies. Our bodies completely change after having a child and we have a tendency to always want to be like others. Ladies, a celebrity will have a child today and two weeks later look the same or even better than they did before pregnancy, they achieve this look though being airbrushed, personal trainers and surgery… but what happens to the rest of us women who are not as lucky financially?
Truth is many ladies out there have the exact same problem. It is part of being a woman and nature. After a child the first thing we get focused on is our breasts and our belly fat. Some of us have felt embarrassed at time with their loved one because they feel embarrassed.
Well, ladies taking care of your breasts is the number one thing to begin doing once you have had your child. As moms I know how busy our schedules can get but with two of our products and just ten minutes of your day you can restore your breasts in no time! Mamonite is a natural breast enhancement brand we offer our enhancement pills and our amazing breast firming cream.
Don't want to say we are experts but … we are! Most of our team has gone through what you have so we know personally how you are feeling. We have created a combo to help your breasts get back to looking sexy, young and confident! Just takes ten minutes a day and your all set! Here's our ten minute plan for you mommy's!
Day 1-
Wake up have breakfast and take one of our natural breast enhancement pill.
Take a hot shower to open up your pores and apply our firming cream after you dry off, make sure you massage your breast until all the cream has been absorbed .
Lunch time-
Take pill #2 with your healthy lunch!
Night –
Take pill #3 with your dinner and right before you lay down for bed, apply a second coat of your cream !
**Repeat Daily**
Breast are a woman's beauty trait and it defines how we feel. Sometimes in life to some women natural fails us and we want to take matters into our own hands. Mother nature sometimes leaves some of us with less than a substantial size for our beautiful breasts. When women hit puberty we always wish to have a good size and when it ends and we are left unsatisfied ….what can we do? The number one solution and option for women has been breast augmentation, which is very pricey, dangerous and very painful.
No longer do we have to put ourselves in danger to feel pretty and confident about ourselves or just to feel a little sexy. Mamonite is a natural breast enhancement pill that has been around for over seven years! What makes the Mamonite natural breast enhancement pill is 10 natural herbs that combined reenacts the process of puberty and naturally creates breast tissue. The process itself takes about 3-6 months and once you have achieved the results they are completely permanent. How much will your breasts grow? Usually your breast will increase in 1-2 cup sizes. There is no chance for them to grow in excess. Once your body adapts to the product it will start to take its course again and your body will determine what the best size for your body is .
Some women have to deal with the fact that hormone imbalance runs in their family. Others just have a low hormone production ability. Because of this, the full
potential of breast growth isn't reached. Breast enhancement pills help pick up where nature left off and get the breasts you're supposed to have,
full and firm and beautiful. In just a few weeks of taking the pills the effects of breast enhancement will be experienced. Just like when you
were a teenager, there's a feeling of fullness in the chest, there are tingling sensations or even itchiness in the skin as your breast area expands once again.
Mamonite is 100% safe and natural. We are the top Natural Breast Enhancement Pill on the market still today. Have questions contact us ! 1-800-853-8213

subset: commoncrawl


text:
Have a Drama-Free Holiday
Keep stress and family feuds at bay by heeding this advice
By Lambeth Hochwald
Special Offer
Ahh, the holidays. A time for singing carols, trimming the tree, eating turkey… and dealing with family drama. If memories of Christmases past have you dreading December 25, cheer up. With these 10 rules, you can have a happy, headache-free holiday—really!
1. Let go of gift guilt.
Your budget is small, but your family is big. And that has you worried: How are you going to afford gifts for everyone? Luckily, you don't have to spend a ton of cash to have a memorable holiday. Gather your family (and call any relatives you normally exchange gifts with) and suggest that this year you do one of the following: Buy presents only for the kids, do a Secret Santa drawing with a $25 price cap or exchange homemade gifts. "As long as you don't spring this idea on your family too close to Christmas, they will have time to adjust," says Aimee Symington, an etiquette expert in Davidson, North Carolina. In this economy, she adds, they'll probably be relieved that you made the suggestion! If someone says no thanks, then he's free to buy what he wants. You, however, shouldn't feel guilty about sticking to your budgetfriendly plan.
2. Don't talk politics.
You know the saying: Never discuss religion or politics. If your relatives didn't get the memo—and you're sick of playing referee every year—be ready to nip it in the bud. At the first sign of Obama-bashing or Palin-baiting, jump in and divert their attention. "Change the subject with a remark like, 'The turkey smells terrific, doesn't it? Let's go check on it,'" says Lisa Gaché, founder and CEO of Beverly Hills Manners. And don't take no for an answer, even if it means gently leading one of the debaters into the kitchen.
If the argument continues the minute you get back, lay down your house rule. "Step in and firmly say, 'Let's just agree to disagree,'" says Gaché. "It doesn't validate either side; it simply allows everyone to own his or her opinion and to stop trying to persuade others." Be ready with a new, more lighthearted topic, to move the conversation forward permanently. Photo: BERNAGER ELIE/Getty Images
3. Tame the tech.
There's nothing more annoying than someone checking her BlackBerry every five minutes in the middle of your conversation—except maybe teens texting at the dinner table. If you want to make your house a no-tech zone for the day, place a basket near the front door with a sign that reads, Let's raise some holiday cheer and leave our electronic devices here, says Symington. It's a fun way to get across your message: We should be connecting with each other, not our smartphones. If anyone balks, play the family card. "Say that you want the focus to be on family and the meaning of the holiday," says Mollie Marti, PhD, a psychologist in Cedar Rapids, Iowa. Are you guilting them into going along? Sure, but it's only for a few hours, so don't sweat it.
4. Take it easy on holiday "spirits."
There's always one relative who has a few too many. To keep Aunt Edna from making a scene—again—don't let her overimbibe in the first place. Easier said than done, you say? Not if you do three things: Designate a family member to serve and monitor alcohol consumption; limit what's served (forgo the pre-dinner drinks and serve only wine with the meal); and relocate your liquor supply (or lock the cabinet) to keep people from helping themselves. If someone asks for a third refill, then a fourth and a fifth, you can always say, "Sorry, I'm all out," says Diane Gottsman, owner of The Protocol School of Texas in San Antonio. "It's a little uncomfortable, but, at the same time, you have to be proactive if you want to ensure that your guests are safe."
If a relative does get drunk despite your best efforts, don't make a big to-do. Escort him out of the room and either ask a sober family member to drive him home or let him crash in your guest room, says Elise McVeigh, founder of Elise McVeigh's Life Camp, which offers manners workshops in Dallas. Photo: Martin Poole/Getty Images
5. Keep gossips in check.
Your niece's miniskirt is way too short. Your cousin shows up without his wife (hmm…those divorce rumors must be true). Every family has stuff to gossip about. But a holiday get-together isn't the time or place for it. "Instead of engaging in it, change the energy and direction of the conversation by elevating the gossiper," says Jill Spiegel, author of How to Talk to Anyone About Anything! The Secrets to Connecting. "Say, 'No, I didn't see Sue's skirt, but I did notice your great haircut. When did you get it done?'" Suddenly, her putdown has been overshadowed by your compliment. With any luck, your positive vibe will be contagious.
If she starts in again, try taking a more direct approach. "Say, 'I understand that you're concerned about Greg coming alone, but I wouldn't want him to overhear us,'" suggests Mindy Lockard, an etiquette consultant in Eugene, Oregon, and founder of TheGraciousGirl.net. Pointing out the possible harmful consequences of her trash talk in a diplomatic way may help put an end to the gossip.
6. Remember, the more the merrier.
You're expecting 10 for dinner but wind up with 14. What happened? Well, your sister decided to bring a date. Your son brought his college roommate. Your mom…well, you get the picture. When unexpected guests show up, stay cool. "Roll with it. Otherwise you'll come off like a diva," advises Mary Mitchell, author of The Complete Idiot's Guide to Etiquette. "If you let your irritation show, you'll make everyone uncomfortable. It's better to be gracious and welcome them." (And make the portions a little smaller!) A good rule of thumb during the holidays: Expect a few surprise guests and plan your menu accordingly. Photo: Jamie Grill/Getty Images
7. Don't send cards if you don't want to.
Your Christmas card list is a mile long and the last thing you want to do is deal with it. Relax. This may be the year to skip the whole holiday card thing entirely. Many people on your list would be just as happy to get a phone call from you instead, says McVeigh. Go through your list and check off the people who'd be truly disappointed not to get a card. Send one to them; phone the rest. Or just email holiday wishes to everyone and call it a day.
8. If you hate your gift, fake it.
Sure, you have a drawerful of ugly sweaters from your cousin Pat. What's one more? Better that than hurt feelings. Besides, your relative may have labored over finding the perfect gift for you, even though she missed the mark, says Lockard. Acknowledge the effort, but keep your appreciation short and sweet. Otherwise, it will come across as phony. "Don't go on and on about how much you love a gift when you don't," says Lockard. "All you need to do is smile and be genuine. Say, 'Thank you so much for thinking of me.' And no matter how much you dislike a present, always send a thank-you note." Photo: Thinkstock
9. Command your kitchen.
It's hard for some moms (and mothers-in-law) to cede their role as ruler of the kitchen. If yours starts horning in on your turf, don't turn it into a confrontation or competition. Try not to overreact if she criticizes your methods, says Andrea Bonior, PhD, a licensed clinical psychologist in Washington, DC. "That will only play into the tension." Instead, head it off by sweetly saying something like, "Thanks for your help, but I'm so used to cooking by myself that it'll take me twice as long if anyone else is here," suggests Mitchell. Then immediately give each matriarch a job to do outside of the kitchen. For example, ask one to set the table while the other leads the grandkids in a centerpiece- or placecardmaking activity.
10. Call it a night when you're ready.
Gracefully putting an end to the evening can be tricky. To get the exiting going—without seeming rude— start cleaning up the kitchen. "If you do this, most guests will get the hint," says Laura Pulido, president of The Protocol Institute in Los Angeles. "Next, mention that you can't believe how the time has slipped away." If your guests are still lounging, be direct, with a touch of humor. "Look at your watch and say, 'Am I the only one here who turns into a pumpkin around this time of night?'" suggests Mitchell. "Then begin gathering coats." After all, tough love—and gentle diplomacy—is often the best way to handle family. Photo: Daniel Grill/Getty Images


text:
Staying Informed
AccessFayetteville provides numerous ways to stay informed about your local government.
Fayetteville Police Chief Greg Tabor announced today the arrest of a Woodland Junior High School student for possession of a firearm on campus.
On September 25, 2013, a Fayetteville police officer was working at Woodland Junior High School when he was informed a student was possibly in possession of a firearm on campus. The officer began investigating the report, and he attempted to approach the student. The student fled on foot from the officer leaving the school campus. As the student was fleeing, he discarded his backpack behind World's Gym (2035 N. College Avenue), and he was apprehended near the business of King Burrito (2175 N. College Avenue) by officers. Fayetteville police recovered the discarded backpack and discovered a loaded handgun inside the backpack. Through the course of the investigation, it was determined the suspect had not threatened anyone with the weapon and nobody was harmed.
The suspect, a fifteen year old male student, was arrested for Possession of a Handgun by a Minor on School Property and Fleeing. The Fayetteville Police Department is working closely with the Fayetteville Public School to ensure the safety of all students and faculty and to create a safe atmosphere for teaching and learning.


text:
Hideshi Okada1,2, N. Chin Lai1,2, Yoshitaka Kawaraguchi3, Peter Liao1,2, Jeffrey Copps4, Yasuo Sugano1,2, Sunaho Okada-Maeda3, Indroneal Banerjee1, Jan M. Schilling3, Alexandre R. Gingras1, Elizabeth K. Asfaw1,2, Jorge Suarez1, Seok-Min Kang1,2, Guy A. Perkins5, Carol G. Au1,2, Sharon Israeli-Rosenberg1,2, Ana Maria Manso1,2, Zheng Liu6, Derek J. Milner7, Stephen J. Kaufman7, Hemal H. Patel2,3, David M. Roth2,3, H. Kirk Hammond1,2, Susan S. Taylor4, Wolfgang H. Dillmann1,2, Joshua I. Goldhaber8 and Robert S. Ross1,2
1Department of Medicine, UCSD School of Medicine, La Jolla, California, USA. 2Veterans Administration San Diego Healthcare System, San Diego, California, USA. 3Department of Anesthesiology, UCSD School of Medicine, La Jolla, California, USA. 4Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, UCSD, La Jolla, California, USA. 5Center for Research in Biological Systems, UCSD School of Medicine, La Jolla, California, USA. 6Wadsworth Center, New York State Department of Health, Albany, New York, USA. 7Department of Cell and Developmental Biology, University of Illinois, Urbana, Illinois, USA. 8Cedars-Sinai Heart Institute, Los Angeles, California, USA.
Address correspondence to: Robert S. Ross, UCSD School of Medicine and VA Healthcare San Diego, Cardiology 111A, 3350 La Jolla Village Drive, San Diego, California 92161, USA. Phone: 858.642.1138; Fax: 858.642.1199; E-mail: firstname.lastname@example.com.
First published September 16, 2013Submitted: April 20, 2012; Accepted: July 18, 2013.
Ischemic damage is recognized to cause cardiomyocyte (CM) death and myocardial dysfunction, but the role of cell-matrix interactions and integrins in this process has not been extensively studied. Expression of α7β1D integrin, the dominant integrin in normal adult CMs, increases during ischemia/reperfusion (I/R), while deficiency of β1 integrins increases ischemic damage. We hypothesized that the forced overexpression of integrins on the CM would offer protection from I/R injury. Tg mice with CM-specific overexpression of integrin α7β1D exposed to I/R had a substantial reduction in infarct size compared with that of α5β1D-overexpressing mice and WT littermate controls. Using isolated CMs, we found that α7β1D preserved mitochondrial membrane potential during hypoxia/reoxygenation (H/R) injury via inhibition of mitochondrial Ca2+ overload but did not alter H/R effects on oxidative stress. Therefore, we assessed Ca2+ handling proteins in the CM and found that β1D integrin colocalized with ryanodine receptor 2 (RyR2) in CM T-tubules, complexed with RyR2 in human and rat heart, and specifically bound to RyR2 amino acids 165–175. Integrins stabilized the RyR2 interdomain interaction, and this stabilization required integrin receptor binding to its ECM ligand. These data suggest that α7β1D integrin modifies Ca2+ regulatory pathways and offers a means to protect the myocardium from ischemic injury.
Mechanical signals have come to be recognized as fundamentally important in many aspects of cardiac function, but their role in ischemic myocardial damage is poorly understood. Specifically, how cell-matrix interactions and cell surface integrins might modulate this process has not been extensively studied (1, 2).
Integrins are a family of transmembrane heterodimeric receptors composed of α and β subunits that serve as the primary link between ECM ligands and cytoskeletal structures (3–5). They act as adhesive receptors and mechanotransducers that can directly initiate intracellular signaling events. Generally, α and β integrin subunits consist of a large extracellular domain, a transmembrane region, and a relatively short cytoplasmic domain (6). Each integrin heterodimer binds to specific ECM proteins or cell surface counter-receptors. Integrin β1 is recognized to have 4 splice variants. The β1A variant is ubiquitously expressed, the β1B variant is detected only in skin and liver (7), and the β1C variant is found in hematopoietic cells (8). The β1D variant is expressed dominantly in striated muscles, including the heart. While embryonic cardiomyocytes (CMs) mainly express the β1A integrin form, perhaps as required for cardiac morphogenesis and plasticity of the developing heart (9), the β1D integrin form becomes upregulated late in gestation, becoming the dominant β1 form in postnatal CMs. β1D has been shown to have tighter binding affinity than β1A to proteins such as talin, thus potentially leading to a particularly strong sarcolemmal-cytoskeletal linkage of the type required in the continuously contracting CM (10).
Interestingly, work has shown that the myocyte β1D integrin form is downregulated in the myocardium after myocardial infarction (MI), and this process has been suggested to play an important role in the decreased function of the heart after MI by reducing the ability of the CMs to interact appropriately with the ECM (11). Integrin β1 partners with several α integrin subunits in the myocyte, including α1, α5, and α7. Integrin α1β1 forms a collagen binding heterodimer, while integrin α5β1 is the major fibronectin (FN) receptor in the myocyte. Integrin α5 is expressed in the embryonic heart and is reduced postnatally, but it can be induced by stress such as cardiac ischemia (12–14). Integrin α7 partners with β1 to form a major laminin-binding (LN-binding) receptor that is highly expressed on the adult myocyte. Like β subunits, alternative splicing of integrin α7 generates cytoplasmic domain variants, with α7B being the dominant α subunit isoform expressed in normal adult CMs (9, 15, 16). Integrin α7 has been shown to be significantly increased after MI (17). Conversely, mice globally deficient in β1 integrin (heterozygous integrin β1 knockout mice) had worsened myocardial function after MI compared with that in control animals, with increased apoptosis (18).
Given this, we hypothesized that increased integrin expression or activity in the CM would offer protection from ischemia/reperfusion (I/R) injury. To test this, we generated Tg mice with CM-specific integrin overexpression (OE) and subjected them to I/R. We found that α7β1D integrin can protect CMs from I/R injury. α7β1D OE reduced excessive Ca2+ entry into mitochondria and prevented mitochondrial permeability transition pore (mPTP) opening after hypoxia/reoxygenation (H/R). In addition, muscle-enriched β1D integrin colocalized with and bound to ryanodine receptor 2 (RyR2). When integrins bound, they stabilized the RyR2 channel interdomain interaction. Thus, CM OE of α7β1D integrin offers a potential novel means to protect myocytes and the intact heart from injury.
Dual expression of α and β integrin subunits is necessary for appropriate cell surface localization on the CM. Functional integrin receptors require interaction between α and β subunits. To determine the requirements to produce increased expression of integrin receptors on the cell surface of adult CMs, we first used an adult rat ventricular myocyte (ARVM) model. Cells were isolated and ARVMs were transduced with recombinant adenoviruses producing β1D integrin, either alone or in combination with α5 integrin or α7B integrin subunits. We chose to use rat as opposed to mouse adult CMs due to the difficulty in maintaining viable, differentiated mouse CMs for the time required for these studies. Protein OE of integrins was confirmed in each group 48 hours after adenoviral infection by analyzing whole cell lysates (Figure 1, A and B). While forced expression of β1D integrin alone significantly increased both the mature and precursor forms of this integrin subunit in the ARVMs compared with those in control infected cells, coexpression of either α5 or α7 along with β1D significantly increased and stabilized expression of the mature β1D integrin subunit as well as the respective α subunit.
Combined expression of integrin α and β subunits is required for highest level of cell surface expression of integrins. (A) Expression of integrins in ARVMs 48 hours after adenovirus infection. Western blot detecting LacZ, β1D integrin (β1D), α5 integrin (α5), and α7 integrin (α7) indicates increased expression of respective integrin subunits following viral infection. (B) Densitometric quantification of integrin expression in virally infected cells. Note that immature (precursor) form of β1D integrin subunit is increased when the cells are infected with the β1D subunit alone but not when they are infected with both α and β subunits. *P < 0.05 vs. LacZ, n = 6 per group (1-way ANOVA). (C) Representative immunofluorescent images of CMs following adenoviral-mediated OE of LacZ (control), β1D integrin alone, or β1D integrin in combination with α5 integrin or α7B integrin. β1D expression is noted on the cell membrane as well as in the cytoplasm when the β1D integrin subunit is overexpressed alone. When combined OE of α and β subunits occurs, the integrin expression is dominantly at the membrane, with little detected in the cytoplasm. Antibodies detect β1D (green), α7 (red), or α5 (green). Nuclei were stained with DAPI (blue). Scale bar: 20 μm. (D) Western blot analysis of β1D integrin expression in cytosolic and cell membrane fractions in ARVMs. As confirmation of the microscopic data, Western blotting shows that β1D integrin singly infected cells expressed integrin dominantly in the cytosolic fraction, while combined αβ integrin subunit infection allowed dominant cell membrane fraction expression.
Next, to address how the OE of integrin subunits might alter the subcellular localization of integrins in the ARVMs, immunofluorescent microscopy was used (Figure 1C). In control cells, endogenous β1D integrin was expressed on the cell surface. With OE of β1D integrin alone, expression was seen in both the cytoplasm and on the cell surface. With combined infection of α5 or α7B subunits along with β1, integrin expression was predominantly at the cell membrane, not the cytoplasm. We confirmed this visual result using Western blot analyses (Figure 1D). These data indicated that increased cell surface expression of myocyte integrins, necessary for their function, required combined expression of α and β integrin subunits. Based on this finding, we used combined infection and transgenesis of α and β integrin subunits for our studies.
CM-specific integrin OE protects against I/R injury in vivo. To directly determine whether increased expression of integrin receptors would be cardioprotective, we generated Tg mice with CM-specific OE of α5, α7, or β1D integrins. For each Tg construct, multiple founder lines were identified (α5 [8 lines], α7 [5 lines], and β1D [10 lines]). Of the lines generated, we chose to study those with varied protein expression levels, which were termed "high," "middle," and "low," respectively (Supplemental Figure 1; supplemental material available online with this article; doi: 10.1172/JCI64216DS1). All of these lines were viable and fertile, and there were no detectable differences in cardiac size or structure between Tg and WT mice (data not shown). Our data from ARVMs indicated the importance of dual α and β subunit expression to produce cell surface expression of integrins. Having these mice, which overexpressed individual integrin subunits, allowed us to interbreed them to produce double Tg (DTg) mice, which had OE of α5β1D integrin or α7β1D integrin in the CMs. DTg mice were created from lines we termed "middle" β1D, "middle" α5, and "high" α7 single Tg mice, so that similar expression levels of β1D were present in the α5β1D and α7β1D DTg mice. This allowed for the best comparisons among groups.
We evaluated the expression of integrins in LV tissue of DTg mice along with that in littermate controls. The mature form of β1D integrin was found to be expressed at 300% of control levels, while the precursor (immature) form of β1D integrin showed decreased expression compared with levels detected in β1D integrin single Tg mice (Figure 2A). Interestingly, β1D expression was increased 2 fold when α subunits were overexpressed in the myocyte. Yet in contrast, forced expression of β1D did not affect α subunit expression level. As in the cultured cells, when both α and β integrin transgenes were expressed in the CM, cell surface expression was detected (Figure 2B). Importantly, there were no significant morphometric or functional differences basally between single subunit Tg or DTg 10-week-old OE male mice as compared with controls (Table 1 and Supplemental Figure 2). Further, there were no differences in integrin-related signaling molecules between DTg mice and controls (Figure 2C).
Functional and morphological analyses of integrin DTg mice. (A) Expression of integrins in Tg mice. Western blot shows mature β1D integrin expression (top band) was increased 3 fold in both the α5β1D and α7β1D DTg mice. In contrast, β1D precursor (immature, bottom band) was decreased compared with β1D single Tg mice. Integrin β1D expression was increased 2 fold in Tg mice with only α subunit OE. When β1D integrin expression was increased in Tg hearts, no significant change in α subunit expression level was detected. *P < 0.05 vs. control. (B) Immunofluorescent microscopy shows increased expression of integrins on the sarcolemmal membrane in α5β1D and α7β1D DTg hearts. Scale bar: 100 μm. (C) Western blot analyses of integrin-related signaling molecules were performed using lysates extracted from intact hearts. There were no significant differences between control or Tg groups.
Cardiac function analysis in 10-week-old Tg mice using echocardiography and invasive catheterization
Next, we tested whether increased integrin expression could protect CMs from I/R injury. For this, male (9- to 12-week-old) mice were subjected to in vivo I/R. We exposed α5β1D integrin OE, α7β1D integrin OE, and littermate Tg-negative controls to 30 minutes of cardiac ischemia, followed by 24 hours of reperfusion (Figure 3A). The area at risk was not different among groups (control: 49.4% ± 8.6%; α5β1D OE: 46.8% ± 7.4%; integrin α7β1D OE: 50.5 ± 2.0; Figure 3B). α7β1D OE mice showed a substantial reduction in infarct size compared with either that of the α5β1D OE or littermate control mice (control: 43.3% ± 4.6%; α5β1D OE: 45.8% ± 2.0%; α7β1D OE: 28.6% ± 2.3%, P < 0.01 vs. littermate control, n = 6; Figure 3C). Therefore, increased CM expression of integrins appears to protect against ischemic damage.
I/R injury in the integrin OE mice. (A) Representative sections of TTC-stained hearts following I/R. (B and C) Quantification was performed by normalizing the myocardial infarct area (MI) to the area at risk (AAR). *P < 0.05 vs. littermate control, n = 8 per group (1-way ANOVA).
Integrin β1 deficiency aggravates I/R injury. To further emphasize how important integrin expression is in protecting the CM, we performed in vivo I/R studies on mice with induced knockout of β1 integrin, specifically in CMs (19). For this, integrin-deficient and control mice were subjected to in vivo I/R. Mice with a "floxed" β1 integrin gene were bred to the tamoxifen-inducible α-myosin heavy chain Mer-Cre-Mer Tg mice (20, 21) to produce α-myosin heavy chain Mer-Cre-Mer/Itgb1fl/fl mice (termed MCM-Itgb1fl/fl mice). When injected with tamoxifen, these mice allow for inducible deletion of β1 integrin in CMs specifically. Diluent-injected mice served as one control group, while Itgb1fl/fl mice (without Cre) injected with tamoxifen served as a second control group. Mice were injected with tamoxifen or control diluent for 5 days. Then, they were examined 4 weeks after injection, a time when we have previously shown that cardiac function is normal (19). Tamoxifen-injected MCM-Itgb1fl/fl mice developed substantial reduction in β1 integrin following Cre induction (Figure 4, A and B). In these knockout mice, percentage MI area/area at risk was increased significantly compared with that in controls (Figure 4, C and D). The area at risk was the same in all groups (Figure 4D). These results support the importance of CM integrins in I/R injury.
I/R injury is increased in mice with CM-specific reduction of β1 integrins. (A and B) Representative Western blot and immunofluorescent analyses for β1D integrin protein in the MCM-Itgb1fl/fl mice 4 weeks after tamoxifen injection show significant reductions in integrin expression compared with MCM-Itgb1fl/fl mice injected with diluent only. Scale bar: 100 μm. (C) Representative sections of TTC-stained hearts. (D) Quantification performed by normalizing the area at risk to LV area and myocardial infarct area to the area at risk. *P < 0.05 vs. littermate control, n = 6 per group (1-way ANOVA).
Integrins protect CMs against reoxygenation injury. In order to analyze the mechanism(s) by which integrins protect against CM I/R injury, we used recombinant adenoviruses to produce increased amounts of integrin protein in an ARVM model. ARVMs were cultured with adenoviruses for 48 hours and then subjected to hypoxia by placement in a chamber filled with N2/CO2 (95:5) for 1 hour. Subsequently, the hypoxic cells were reoxygenated, and control cells continued incubation for 1 additional hour in a normoxic environment. Cell samples were then analyzed using trypan blue staining and lactic dehydrogenase (LDH) release as markers of cell damage. Cells with an increased amount of α7β1D integrin were protected against reoxygenation injury to a greater extent, compared with control (LacZ) cells or ones in which α5β1D integrin was increased (Figure 5, A and B). The significant differences among groups were apparent only after H/R and not after hypoxia alone. To determine a potential mechanism for this cell death, we evaluated apoptosis, but no significant differences were found among groups (Supplemental Figure 3). Further, we inquired whether this protective effect might occur by modulating important integrin-related signaling pathways. No differences were detected among groups in the activation states of major integrin signaling molecules, including focal adhesion kinase (FAK), integrin linked kinase (ILK), PYK2, Src, and related downstream kinases, p38 and Akt (Supplemental Figure 4). Therefore, as we found in vivo, increased expression of α7β1D integrin protected CMs against reoxygenation injury.
Integrin heterodimers protect CMs from reoxygenation injury via prevention of mitochondrial membrane potential reduction. (A and B) Cell survival was improved by α7β1D integrin OE. (A) Survival rate of cells assayed by trypan blue staining after H/R injury. α7β1D integrin OE inhibited cell death compared with that in control cells. In contrast, α5β1D integrin had no beneficial effect against H/R. HPF, high-power field. (B) Cell survival evaluated by LDH release after H/R confirmed data in A. *P < 0.05 vs. LacZ following reoxygenation (1-way ANOVA). (C) α7β1D integrin OE allows for maintenance of mitochondrial membrane potential during reoxygenation injury. Mitochondrial membrane potential was measured with the membrane potential–sensitive dye JC-1 after H/R. The excitation ratio (red/green) indicates the mitochondrial membrane potential. Cells in which α7β1D was overexpressed maintained the mitochondrial membrane potential during reoxygenation injury, in comparison with cells with control virus (LacZ) or α5β1D integrin. *P < 0.05 vs. LacZ (1-way ANOVA). (D and E) α7β1D integrin OE allows for maintenance of mitochondrial [Ca2+] during reoxygenation. Mitochondrial [Ca2+] was measured by pericam. (D) During normoxia, there was no significant difference among groups. (E) During reoxygenation, α7β1D allowed for maintenance of mitochondrial [Ca2+] in comparison with cells overexpressing LacZ or α5β1D in which mitochondrial [Ca2+] increased. *P < 0.05 vs. LacZ (1-way ANOVA).
Integrin β1D OE protects mitochondrial membrane potential in ARVMs subjected to H/R injury. Mitochondria play an important role not only in energy production, but also in Ca2+ homeostasis and cell survival/death of CMs. The combination of Ca2+ overload and oxidative stress can open a nonspecific pore in the inner mitochondrial membrane known as the mPTP. The mPTP is normally held in the fully closed state, but, under some pathological conditions, it can open, collapse mitochondrial membrane potential, and predispose cells to death. To test whether integrin OE modified mitochondrial membrane potential (Ψμm) during reperfusion injury, we measured it using the membrane potential–sensitive dye, 5,5′,6,6′–tetrachloro-1,1′,3,3′-tetraethylbenzimidazoly-carbocyanine iodide (JC-1). As shown in Figure 5C, OE of α7β1D integrin prevented reduction of mitochondrial membrane potential that occurred in the reoxygenated cells expressing either the control LacZ virus or α5β1D integrin.
We next measured mitochondrial [Ca2+] using mitochondrial pericam (22, 23). During normoxia there were no significant differences among groups (Figure 5D). In contrast, during reoxygenation α7β1D OE inhibited increases in mitochondrial [Ca2+] that occurred in control cells as well as α5β1D integrin–overexpressing cells (Figure 5E). These results suggested that increased expression of α7β1D inhibited excessive Ca2+ entry into mitochondria and prevented mPTP opening after H/R injury.
In previous reports, it was shown that oxidative stress and/or mitochondrial Ca2+ overload could provoke mPTP opening (24–26). Therefore, we next tested whether integrin OE would modulate oxidative stress protein expression. Western blot analyses were performed for iNOS, 12-LO, ECSOD, Cu/ZnSOD, MnSOD, and Cox-2. There was no significant difference among any treatment group under normoxic conditions or following H/R (Supplemental Figure 5A). Likewise, superoxide anion quantification was performed after H/R injury, and no differences were noted among the various groups (Supplemental Figure 5B).
Effect of integrins on myocyte Ca2+-handling proteins in H/R — β1D integrin colocalizes with and binds to RyR2. To assess how α7β1D could reduce mPTP opening and control cytosolic and mitochondrial [Ca2+], we evaluated how integrin OE might affect Ca2+-handling proteins. First, we performed Western blot analyses to evaluate expression of Ca2+-handling proteins, including L-type Ca2+ channel (LTCC), sodium-Ca2+ exchanger-1 (NCX-1), SERCA2a, phospholamban (PLB), and phospho-PLB proteins, in ARVMs under normoxic conditions and also following H/R. No significant differences were detected in expression of any of these proteins among groups (Supplemental Figure 6A). Further, to examine whether β1D integrin might interact with any of these proteins, coimmunoprecipitations (co-IPs) were performed, but no interactions were detected (Supplemental Figure 6B).
In contrast to the other proteins examined, co-IPs showed that RyR2 interacted with β1D integrin under endogenous conditions. This interaction was detected in human heart tissue as well as samples obtained from rats (Figure 6, A and B). In addition, binding was increased in CMs when this integrin receptor was overexpressed (Figure 6, C–E).
Integrins interact with RyR2 in human and rat heart. (A) Human and (B) rat heart protein was immunoprecipitated using anti-β1D integrin or RyR2 antibodies and then immunodetected with the reciprocal antibody. (C–E) RyR2 binding and β1D integrin were increased by integrin OE. (C) IP with a RyR2 antibody and detection with an anti-β1D integrin antibody. (D) No differences in RyR2 were detected in the various input lysates. (E) Densitometry of immunoprecipitated RyR2-β1D integrin product. LacZ control = 1. Other samples are displayed relative to control. *P < 0.05 vs. LacZ, n = 6 per group (1-way ANOVA).
Using immunofluorescent microscopy, we next showed that integrins are clearly located on T-tubules (Figure 7, A and B). Colocalization of β1D integrin and junctophilin-2 or wheat-germ agglutinin, both markers of membranes/T-tubules, was found in isolated ARVMs (27, 28). Similarly, microscopy also showed that β1D integrin and RyR2 were colocalized in the T-tubules of CMs (Figure 7C). Moreover, not only was the β1D subunit localized to T-tubules in CMs, but we also detected α5 and α7 integrins in T-tubules when these α integrin subunits were overexpressed (Supplemental Figure 7, A–C). β1D colocalization with RyR2 was also confirmed and correlated using 3D rendering techniques (Figure 7D) (Pearson coefficient of 0.83 ± 0.09 [n = 10]). This result was supported by companion studies using immunogold electron microscopy in which colocalization of β1D and RyR2 was also observed (Figure 7, E–G). These results show that β1D integrins are positioned in T-tubules in which they colocalize and complex with RyR2.
Integrins colocalized with RyR2 in T-tubules. (A and B) β1D integrin localizes in T-tubules. Integrin (green) with (A) wheat germ agglutinin (WGA, red) and (B) junctophilin-2 (JP-2, red). Scale bar: 20 μm. (C–G) β1D integrin colocalizes with RyR2 in CMs. (C) Immunofluorescent microscopy: β1D integrin (green) and RyR2 (red) colocalized. Scale bar: 20 μm. (D) Confocal 3D analysis shows β1D integrin (green) and RyR2 (red) are tightly colocalized (Pearson coefficient of 0.83 ± 0.09 [n = 10]). Scale bar: 20 μm. (E–G) Immunoelectron microscopy shows colocalization of β1D integrin and RyR2. (E) Immunoelectron microscopy of ARVM T-tubule. Scale bar: 200 nm. The boxed area is shown at higher magnification in F and G. (F) Magnified image of T-tubule and SR. The green arrow indicates RyR2 (6-nm gold particle); the red arrow indicates β1D integrin (10-nm gold particle); and blue arrows indicate colocalized particles in the T-tubule. Scale bar: 100 nm. (G) Diagram of F. Blue arrows indicate colocalization of β1D integrin (red dots) and RyR2 (green dots). Scale bar: 100 nm.
We also examined the expression of total and phosphorylated RyR2. While total RyR2 expression did not vary among groups (Figure 8A), RyR2 Ser2808 phosphorylation, which can increase RyR2 open probability and potentially sarcoplasmic reticulum (SR) Ca2+ release (29), was reduced in α7β1D-infected cells (Figure 8, A and B). No change was detected in phosphorylation of RyR2 at Ser2814. In addition, RyR2 Ser2808 phosphorylation was found to be decreased in heart tissue from α7β1D OE mice as compared with that from α5β1D OE mice. In contrast, RyR2 Ser2808 phosphorylation was increased when β1 integrin expression was reduced specifically in CMs (Supplemental Figure 8, A and B).
Integrins modulated RyR2 Ser2808 phosphorylation. (A) β1D and α7β1D integrin reduce phosphorylation of RyR2 protein at Ser2808 but not Ser2814, following H/R (n = 6 per group). (B) Densitometry of Western blot in A. *P < 0.05 vs. LacZ, **P < 0.05 α7β1D vs. B1D (1-way ANOVA).
To confirm the β1 integrin–RyR2 interaction and determine the precise location within RyR2 that binds to β1D integrin, a full-length RyR2 cDNA or 7 different truncated and HA-tagged RyR2 fragments were transfected into human embryonic kidney (HEK) cells along with a full-length β1D integrin cDNA expression vector. First, we confirmed that β1D bound with full-length RyR2 in this system, as it did endogenously in CMs. Then, we evaluated which portion of RyR2 directed this binding. Using the truncated fragments shown in Figure 9A, we found that the N terminus of RyR2 (residues 1–530) directed this binding, while no interaction was detected with any of the other 6 fragments (Figure 9B).
Integrins interact with the RyR2 receptor. (A) RyR2 fragments. Numbers represent amino acids spanned by the fragment. (B–D) Binding site of RyR2 and β1D integrin. The bottom blot in each panel is a Western blot of RyR2 fragment expression in HEK293 whole cell lysates. (B) Seven unique HA-tagged RyR2 fragments from A were transfected into HEK293 cells with full-length β1D integrin cDNA. IPs performed 48 hours after transfection using β1D integrin and anti-HA (for RyR2) antibodies showed that β1D integrin only bound the N-terminal domain of RyR2 (1–530) (arrow indicates the unique band only detected in the bound fragments). (C) Additional IPs using Flag-tagged RyR2 fragments 1–217, 205–395, and 392–532. Only the RyR2 1–217 fragment bound β1D integrin (arrow indicates the unique band only detected in the bound fragments). (D) IPs using Flag-tagged RyR2 fragments 89–395, 110–395, and 142–395. All fragments bound to β1D integrin, suggesting the binding site was within RyR2 residues 89–204. (E) RyR2 fragments examined using a peptide array. RyR2 amino acids 165–175 bound to β1D integrin. (F) IPs performed using RyR2 (fragment 1–217) WT or mutant (amino acids 169 [Arg {R} to Gln {Q}]) fragments. Binding between the WT RyR2 (fragment 1–217) domain and β1D integrin was destabilized by the mutation (arrow indicates the unique band only detected in the bound WT fragment, absent in the 169RQ mutant). Light chain indicates the immunoglobulin light chain detected as a nonspecific band in all samples. The bottom blot is a Western blot of WT and mutant RyR2 fragments in whole cell lysates.
Next, we performed studies to precisely determine the interaction site between the RyR2 N-terminal domain and β1D integrin. A recent report detailed the structure of the RyR2 N-terminal domain (30). This work indicated that the RyR2 N terminus had 3 major domains: (a) residues 1–205, which show structural homology with the Ca2+ release channel inositol-1,4,5-trisphosphate (IP3) receptors (31, 32); (b) the MIR domain (residues 206–394) that is named after the 3 proteins in which it occurs (mannosyltransferase, IP3 receptor, and RyR2) (33); and (c) the RIM domain (residues 395–532), which is formed by a bundle of 5 α-helices (30). Based on this work, we constructed 3 unique RyR2 N-terminal domain fragments and showed that β1D integrin interacted with the IP3 receptor domain (residues 1–217) (Figure 9, C and D). Then, using additional RyR2 fragments as well as a peptide array, we narrowed the binding region specifically to RyR2 amino acids 165–175 (Figure 9E). To definitively prove that this binding site was essential for the integrin-RyR2 interaction, we mutated Arg169 within the central portion of this binding region to Gln. This single amino acid mutation destabilized the binding between the N-terminal domain of RyR2 and β1D integrin (Figure 9F). Together, these results definitively show that β1D integrin binds to RyR2 IP3 receptor domain at amino acids 165–175.
The β1D cytoplasmic domain is specifically required for H/R protection. The preceding data focused on the function of the β1D variant, since it is the dominant isoform found in adult CMs. To specifically evaluate whether the "D" cytoplasmic domain of β1 integrin was necessary for the beneficial effects noted when ARVMs were subjected to H/R, we compared the function of α7β1A with that of α7β1D. Increased expression of α7β1A integrin had no protective effect against H/R injury, in comparison with that of α7β1D (Figure 10, A and B). Further, α7β1A integrin had no effect on mitochondrial membrane potential or mitochondrial [Ca2+] in comparison with α7β1D (Figure 10, C and D). Finally, in contrast with β1D, β1A did not interact with RyR2 in IP assays (Figure 10, E and F). These results suggest that β1D integrin, which is expressed dominantly in muscle, plays an important protective role in H/R injury and functions uniquely as compared with the ubiquitously expressed β1A integrin isoform.
The β1D integrin cytoplasmic domain variant is necessary for protection from reoxygenation injury. (A and B) Protection from reoxygenation injury occurs with the β1D but not the β1A integrin splice variant. (A) Survival rate of cells assayed by trypan blue staining after H/R injury. α7β1D integrin OE inhibited cell death compared with that in control cells. In contrast, α5β1D integrin had no beneficial effect against H/R. *P < 0.05 vs. LacZ (1-way ANOVA). (B) Cell survival evaluated by LDH release after H/R confirmed data in A. *P < 0.05 vs. LacZ following reoxygenation (1-way ANOVA). (C) Mitochondrial membrane potential was maintained by α7β1D but not α7β1A integrin following H/R injury. Mitochondrial membrane potential measured with the membrane potential–sensitive dye JC-1 after H/R. The excitation ratio (red/green) indicates the mitochondrial membrane potential. Cells in which α7β1D OE maintained the mitochondrial membrane potential during reoxygenation injury, in comparison with control virus (LacZ) or α7β1A integrin. *P < 0.05 vs. LacZ (1-way ANOVA). (D) Mitochondrial [Ca2+] measured using pericam excitation ratio during reoxygenation. In cells infected with α7β1D, mitochondrial [Ca2+] was maintained in comparison with the LacZ (control) or α7β1A-infected cells in which it increased. *P < 0.05 vs. LacZ (1-way ANOVA). (E and F) α7β1A did not interact with RyR2 in ARVM protein extracts. IPs were performed using IgG as a negative control and (E) anti-β1A integrin or (F) RyR2 antibodies.
The β1D cytoplasmic domain stabilizes the RyR2 protein. The IP3 receptor domain is located in the N terminus of RyR2. The N-terminal and central regions of RyR2 are predicted to interact with one another and to stabilize this channel via interdomain interactions (34–36). To show that β1D could stabilize the RyR2 channel, we used a fluorescence resonance energy transfer (FRET) sensor, in which yellow fluorescent protein (YFP) was inserted into RyR2 after residue Ser437 of the N-terminal region, and a cyan fluorescent protein (CFP) was inserted after residue Ser2367 of the central region. This synthetic FRET sensor forms a dual YFP- and CFP-labeled RyR2 (RyR2S437-YFP/S2367-CFP) (36). The FRET sensor was transfected into HEK293 cells along with expression vectors for full-length α7, β1A, or β1D integrin subunits. Then, the FRET signal was evaluated in live cells (Figure 11, A and B).
The β1D cytoplasmic domain stabilizes RyR2; integrin heterodimers require ECM binding for RyR2 stabilization. (A) FRET image of RyR2S437-YFP/S2367-CFP expressed alone or with α7, β1A, or β1D integrin (original magnification, ×63). (B) Graphic FRET ratio. Relative signal detected in the RyR2-transfected cells was set as 1. FRET signal detected in other samples is displayed relative to control. The RyR2 sensor FRET ratio was increased by dantrolene, an RyR2 stabilizer. β1D integrin cotransfected with the sensor increased the FRET ratio, indicating increased RyR2 stability. No change was seen with α7 or β1A integrin (*P < 0.05 vs. RyR2-transfected cells, n = 20 cells per group). (C) Western blots of control and β1D integrin stably transfected OE cells (OE). β1D integrin precursor (P) was substantially increased in OE cells, but the higher MW mature (M) form increased minimally. No β1D integrin was detected in untransfected cells. GAPDH was used as a loading control. (D) Graphic FRET ratio. FRET ratio in β1D OE cells transiently transfected with RyR2 alone and plated without ECM was set as 1. FRET detected in other samples is displayed relative to this amount. Cells expressing β1D integrin alone showed no change in FRET signal regardless of ECM coating, indicating that there was no stabilization of RyR2. With OE of the FN-binding integrin α5β1D and plating on FN matrix, a stronger FRET signal was found compared with cells plated on LN or no substrate. Cells expressing the LN-binding α7β1D integrin had the most robust FRET signal when plated on LN (*P < 0.05 vs. β1D OE cells transfected with RyR2 alone).
An increase in the average FRET ratio measured from this sensor indicates a more stable interaction between the IP3 receptor and central RyR2 regions. The average FRET YFP/CFP ratio of cells expressing the sensor alone was increased significantly by 10 μM dantrolene, a substance known to stabilize the interdomain interactions of the RyR2 channel (37). Cotransfection of the sensor with α7 integrin, or β1A integrin alone, had no significant effect on the FRET ratio, while cotransfection with β1D caused a significant increase (Figure 11B). These results suggest that the β1D cytoplasmic domain stabilizes the RyR2 channel.
To further confirm the role of αβ integrin heterodimers in cardioprotection, particularly in contrast to single integrin subunits (e.g., β1D), we created a permanently transfected (stable) cell line that expressed β1D integrin (Figure 11C). We then cotransfected the RyR2 FRET construct into this stable cell line, along with vectors that expressed either α5 or α7 integrin subunits. In doing so, we created a FN-binding integrin (α5β1D) or a LN-binding integrin (α7β1D). Cells were examined for FRET signals when they were plated on ECM ligands that specifically bind to the integrin receptor that was produced, i.e., FN was used when α5β1D was tested, and LN was used when α7β1D was studied. As shown in Figure 11D, when cells only expressed β1D without a companion α integrin subunit, there was no change in FRET signal, regardless of the ECM coating, indicating that there was no stabilization of RyR2. Yet, when cells overexpressed the FN-binding integrin α5β1D and were plated on FN matrix, they elicited a stronger FRET signal compared with that when these cells were plated on either LN or no ECM substrate. Similarly, cells expressing the LN-binding integrin, α7β1D, had the most robust FRET signal when they were plated on LN. Given these data, we examined whether cells expressing α5β1D and plated on its suitable ECM ligand, FN, could also offer a beneficial effect against H/R injury, as was noted when α7β1D-expressing cells were plated on their appropriate ECM ligand, LN. For this purpose, ARVMs were infected with LacZ or α5β1D recombinant adenoviruses, and cells were plated on either LN matrix alone (which would bind to α7β1D but not α5β1D) or on a mixture of LN and FN, so that an appropriate matrix ligand for α5β1D was available. Subsequently, H/R injury was performed as above. Cell samples were then analyzed using trypan blue staining and LDH release as markers of cell damage. With the combined matrix coating, α5β1D integrin OE displayed a beneficial effect against H/R, while no protection was noted when the cells were plated on LN alone (Supplemental Figure 9). These data support the finding that integrin–ECM ligand engagement is necessary for protection against H/R injury.
The current study shows that α7β1D integrin can protect CMs from I/R injury. Specifically, we showed that (a) combined expression of α and β integrin subunits is needed for expression of integrin receptors on the CM membrane, (b) α7β1D integrin OE protects against I/R injury in vivo and in cultured CMs, (c) loss of β1 integrins from the CM leads to deleterious effects following short-term I/R, (d) α7β1D OE reduces mPTP opening in the face of H/R and also limits injurious changes in mitochondrial Ca2+, and that β1D integrin (e) colocalizes with RyR2, (f) reduces phosphorylation of RyR2, (g) interacts with the N-terminal RyR2 domain at amino acids 165–175, and (h) stabilizes interdomain interactions of the RyR2 channel. ECM ligand binding of integrin was found to be necessary for its cardioprotective effects. Thus, α7β1D integrin OE offers a potentially novel means to protect myocytes and the intact heart from injury.
Previous work had shown that increased expression of integrins can protect against skeletal muscle sarcolemmal damage in mouse models of muscular dystrophy (38, 39). In Duchenne muscular dystrophy, caused by mutations in the dystrophin gene, the dystrophin-glycoprotein complex (DGC) is compromised and sarcolemmal integrity is reduced, but expression of integrins, including α7β1D, is increased, likely in compensation for loss of DGC components (40, 41). As in skeletal muscle studies that tested the effects of increased integrin expression in protection of dystrophic skeletal muscle, we found that combined expression of both integrin α and β subunits was required for appropriate expression of integrin receptors on the CM membrane. In contrast to the skeletal muscle studies, we found that β subunit expression did not provoke compensatory increases in α subunit expression but that dual expression of the α and β subunits was required (39) to increase integrin expression on the sarcolemma. Likewise, our data showed that coexpression of α5 and α7 integrin can increase both mature and precursor forms of β1D integrin and change its subcellular localization. These data are consistent with prior work in other cell types that showed that β1 subunits are generally synthesized in excess over α subunits (42). When expression of α subunits was increased, they assembled with β1 subunits, allowing for transport of the integrin heterodimer through the Golgi apparatus and then presentation of the αβ1 receptor on the cell surface (42).
Importantly, we found that integrin receptors are positioned at CM T-tubules. The T-tubule system is the dominant location for excitation-contraction coupling in ventricular myocytes (28). Integrin receptors require ECM binding to function as adhesive receptors, mechanotransducers, and direct intracellular signaling events. As noted in prior reports, ECM clearly exists at the T-tubule (43). The finding that integrins are critically positioned in the T-tubule is consistent with our results that integrin receptors participate in modifying proteins known to be essential for CM Ca2+ regulation and therefore can potentially protect against Ca2+-mediated myocyte injury. Our data indicated that the protective effect offered by α7β1D integrin to prevent Ca2+ overload does not appear to occur via an antiapoptotic mechanism but likely occurs by inhibition of cellular necrosis (44).
We also found that α7β1D integrin OE was inversely correlated with phosphorylation of RyR2 Ser2808. RyR2 phosphorylation is thought to be important in Ca2+ homeostasis, yet linking phosphorylation to specific changes in the single-channel function of RyR2 has remained quite controversial. Some prior work has shown that Ser2808 can be hyperphosphorylated by PKA (45) and that PKA-dependent phosphorylation of RyR2 can increase the open probability of RyR2 (45–47). In contrast, work by others has shown that dephosphorylation of RyR2 can also increase open probability, indicating that there must be an inhibitory component to phosphorylation (46, 48, 49). The controversy about the function of RyR2 phosphorylation in the myocardium is highlighted by recent work from Houser's group (50), in which genetically manipulated mice with a RyR2 S2808A mutation were produced that could not undergo PKA-mediated hyperphosphorylation at the RyR2 S2808 site. Data from this mouse model strongly indicated that phosphorylation at this site was not linked to development of cardiac dysfunction after MI. A limitation of our study is that we cannot precisely link RyR2/integrin binding directly to RyR2 phosphorylation. This will require future studies that would ideally use a genetically manipulated knockin mouse model with specific mutation of RyR2 amino acid 169, which we showed to be required for RyR2/integrin binding.
OE of α7β1D integrin inhibited mPTP opening and also inhibited the increases in mitochondrial [Ca2+] that occur after myocyte H/R. mPTP opening can occur via 2 different mechanisms: oxidative stress or Ca2+ overload. In some reports, mPTP opening correlated to a greater extent with changes in oxidative stress than changes in [Ca2+] (25, 26). However, here we did not find integrins to cause changes in oxidative stress–related proteins. Ca2+ overload during I/R injury has also been shown to open the mPTP, resulting in collapse of the mitochondrial membrane potential, uncoupling of the respiratory chain, and efflux of cytochrome c and other factors, which can lead to cell death via apoptosis or necrosis (51). Many factors can change the mitochondrial [Ca2+] required to open the mPTP, and several of these may play a role in mediating mPTP opening during ischemia and reperfusion (24–26, 52, 53).
A primary means through which mitochondria uptake Ca2+ is via the mitochondrial calcium uniporter (54). Recent studies have demonstrated that mitochondrial Ca2+ uptake can be dependent on anatomical-functional microdomains established between the SR and mitochondria and that these microdomains play crucial roles separate from more global changes in cytosolic Ca2+ (55). While the precise mechanism whereby α7β1D protects CMs from "cell death via Ca2+ overload" is not fully understood, we would speculate that integrin OE and interaction with RyR2 reduces mitochondrial Ca2+ loading by altering Ca2+ availability from adjacent microdomains between SR and the mitochondrial membrane (56, 57). RyR activation by Ca2+ is very sensitive to the geometric arrangement of RyRs and LTCCs (58). Therefore, it is also possible that integrin binding to RyR2 alters critical interactions of RyR2 with other proteins such as LTCCs, leading to reduced Ca2+ influx. More detailed future experiments will be required to directly confirm these hypotheses.
This study is the first report showing that CM integrins, and specifically the β1D but not β1A cytoplasmic isoform variant, bind to RyR2. We detected this in human heart and then performed further studies in other species. Detailed analysis showed that β1D bound to the RyR2 N terminus domain at amino acids 165–175. For this, we used a series of IP studies, transfection experiments in HEK cells, and a peptide array. From these combined approaches it is clear that RyR2 and β1D integrin bind, but we cannot absolutely exclude that this interaction occurs through an intermediary protein.
The RyR2 N-terminal and central domains have been shown to physically interact with one another in 3D space, and changes in the strength of their interaction affect channel gating (34, 36). The interaction between these domains can serve as a regulatory switch for channel gating activity: a tight interaction or "zippering" of these domains stabilizes the channel in the closed state. Prior work has shown that mutations in either domain can weaken their interaction, thus increasing their tendency toward "unzipping," causing activation and leakiness of the Ca2+ release channel (33, 59, 60). Interestingly, mutation of RyR2 amino acid 169, which is essential for integrin-RyR2 binding, has been previously linked to catecholaminergic polymorphic ventricular tachycardia, in which RyR2 dysfunction is caused by channel destabilization (30). Future studies will be required to see how integrin-RyR2 binding might be related to this phenotype. Further, it has been reported that dantrolene, which stabilizes RyR2, can attenuate I/R injury in various organs, including heart (61–63). Given this prior work, combined with our current findings, we suggest that β1D integrin contributes to RyR2 channel interdomain stabilization in the myocyte and, as above, in doing so can affect [Ca2+] microdomain availability within the myocyte.
The current study shows that ECM substrate binding to cell surface integrins stabilizes RyR2. It is interesting to note that cells in which we overexpressed the single subunit β1D integrin alone also showed evidence of RyR2 stabilization. We suggest that when β1D protein is increased, it heterodimerizes with endogenous α integrin subunits already present in these cells, allowing for expression of increased numbers of functional cell surface integrin receptors that can bind ECM ligand. It is for this reason that increased expression of β1D alone can still offer some degree of cardioprotection.
An important question is why β1D integrin has a preferential effect in allowing for cardioprotection and RyR2 binding, as compared with the β1A isoform. The β1D and β1A integrin isoforms are highly similar and vary only in their cytoplasmic domains. Like most β integrin subunits, the cytoplasmic domains of β1D and β1A are quite short (β1A = 47 amino acids, β1D = 50 amino acids) (10, 64). Both variants have the first 26 cytoplasmic N-terminal amino acids in common. Of the remaining sequence, β1D only differs from β1A by 13 amino acids. There is precedent for proteins showing exclusive binding to a specific β1 integrin cytoplasmic variant. For example, both integrin cytoplasmic domain–associated protein-1 (ICAP-1) and CD98 bind to the β1A but not the β1D integrin cytoplasmic domain and in doing so can modulate β1A integrin activation (65, 66). In addition, it has been shown that there are functional differences between the β1A and β1D isoforms, in that the β1D isoform binds more tightly to talin-2, which could allow for stronger ECM-cytoskeletal linkages required in myocytes (10). Here, we have shown that RyR2 binds preferentially to β1D but not β1A, the first protein to our knowledge to show this preference. Where RyR2 binds precisely in the β1D cytoplasmic domain, how this interaction leads to cardioprotection, and whether the RyR2-β1D interaction is the only means that offers the cardioprotection require further investigation.
In summary, our data clearly support an important physiological and new cardioprotective function of integrins in the CM. Basally, we would suggest the endogenous integrin/RyR2 interaction contributes to CM Ca2+ homeostasis by stabilizing the RyR2 channel. This is supported by our data showing that β1D integrin and RyR2 interact and our FRET studies indicating how integrin can stabilize the RyR2 channel and that β1 integrin–deficient hearts are more prone to ischemic damage than controls. In contrast, we would advocate that, in the face of pathophysiological stress produced by insults such as I/R, having an increased amount of α7β1D integrin expressed in CMs can protect the myocyte from damage. Perturbations in RyR2 function have been shown to be present in the face of I/R, and modulating their function has been proposed previously as a means toward cardioprotection (67). Integrin OE reduces mPTP opening and detrimental effects of elevated mitochondrial Ca2+ and stabilizes RyR2 interdomain interactions. While further studies are clearly required to prove this tenet, we would propose that the integrin OE may modify microdomain coupling between SR and mitochondria to ultimately protect the myocyte/myocardium (56, 57). While these results highlight the protective effect that occurs in part through α7β1D integrin interacting and colocalizing with RyR2, as above, it is possible that other integrin functions are also important for this therapeutic effect. Further data are necessary to elucidate all of the precise mechanism(s) that allow integrin OE to protect the heart from injury.
Further details regarding the materials and methods are available in the Supplemental Methods.
Animals, cells, and human heart tissue. Tg mice with CM-specific OE of integrin α5, α7, or β1D were produced in a C57BL/6 background. Full-length integrin α5 (supplied by M. Valencik, University of Nevada, Reno, Nevada, USA), α7 (68), or β1D (69) cDNAs were cloned into a vector containing the α-myosin heavy chain promoter (70) and were used for microinjection in the UCSD Transgenic Core. Inducible and constitutively active CM-specific β1 integrin knockout mice were created as reported previously (19, 20).
CMs were isolated from adult mice or adult Sprague-Dawley rats as described previously (71).
Human ventricular tissue was obtained as either explanted samples at the time of heart transplant or from organs judged unsuitable for transplantation. Samples were either frozen rapidly in the operating room in liquid N2 or stored on ice for less than 4 hours at the time of acquisition. Then, all specimens were frozen at –80°C and thawed for processing.
H/R in isolated CMs. CMs were cultured on plates coated with 10 μg/ml LN at 37°C. Hypoxia was induced by replacing the air content with a 95% N2 and 5% CO2 gas mixture at 2 l/min in a metabolic chamber (Columbus Instruments) and by replacing the media with a thin film of glucose-free media (glucose-free DMEM, Invitrogen), which covered the cells for 60 minutes. Subsequently, the culture was "reoxygenated" for 60 minutes by replacing the media with normal maintenance media and by incubating the cells in 21% O2 and 5% CO2. Cell death was quantified by trypan blue staining and by analyzing LDH release (Cytotoxicity Detection Kit; Roche) as a marker of cell damage.
Mitochondrial [Ca2+] measurements and measurement of mitochondrial membrane potential. Adv-CMV-mito-pericam and its use have been described previously (22, 23). Mitochondrial membrane potential was measured using a JC-1 assay. After hypoxia treatment, as described above, JC-1 at a concentration of 10 μg/ml (Invitrogen) was added to the medium for 10 minutes. Cells were then washed twice in PBS. At 30 and 60 minutes following onset of reoxygenation, fluorescence measurements were performed at room temperature as described above with a Nikon Diaphot epifluorescent microscope. Fluorescence emission was filtered at 485 and 580 nm and directed to a photomultiplier tube (23).
In vivo I/R study. Mice anesthetized with pentobarbital (80 mg/kg) were mechanically ventilated, and ischemia was produced by occluding the left coronary artery with a 7-0 silk suture on a tapered BV-1 needle (Ethicon, Johnson & Johnson) for 30 minutes. Following 30 minutes of occlusion, the ligature was released, and the heart was reperfused for 24 hours. The area at risk was determined by staining with 1% Evans blue (1.0 ml; Sigma-Aldrich). The heart was immediately excised and cut into 1-mm slices (McIlwain tissue chopper, Brinkmann Instruments). The LV was counterstained with 1% 2,3,5,-triphenyltetrazolium chloride (Sigma-Aldrich). Images were analyzed by Image-Pro Plus (Media Cybernetics), and infarct size was determined by planimetry.
RyR2 cDNA fragments. PCR was used to produce 7X-HA–tagged RyR2 fragments and 6X-FLAG–tagged RyR2 fragments from the full-length RyR2 cDNA (supplied by S.R. Wayne Chen, University of Calgary, Calgary, Alberta, Canada). PCR primers used for this process are provided in Supplemental Table 1. Products were cloned into pcDNA3.1 using SalI or XhoI with BamHI or EcoRI restriction sites and sequenced to confirm fidelity. To produce the R169Q mutation located within the RyR2 IP3 receptor domain, the RyR2 cDNA was modified using the QuikChange Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer's instructions. All constructs were confirmed by sequencing.
Statistics. Values are shown as mean ± SEM. Significance was evaluated with ANOVA, using GraphPad Prism software. Values of P < 0.05 were considered significant.
Study approval. All animal use protocols were approved by the Veterans Administration San Diego Institutional Animal Care and Use Committee. These investigations conformed to the Guide for the Care and Use of Laboratory Animals published by the NIH. All investigations using human heart were approved by Stritch School of Medicine, Loyola University and Veterans Administration San Diego. Samples of LV tissue were obtained from Loyola University Medical Center's Cardiovascular Institute Tissue Repository and from the Gift of Hope Organ and Tissue Donor Network. The investigation conformed to the principles outlined in the Declaration of Helsinki. A detailed protocol and informed consent document were reviewed by Loyola University Medical Center's Institutional Review Board prior to tissue procurement. Explanted human LV tissue from patients undergoing heart transplantation for nonischemic dilated cardiomyopathy were obtained following informed consent. Donor heart tissue judged unsuitable for cardiac transplantation was similarly obtained following informed consent from organ donor family members by the Gift of Hope Organ and Tissue Donor Network.
View Supplemental data
The authors wish to thank Clayton Buck (University of Pennsylvania) and Lou Terracio (NYU) for the α5 integrin adenovirus, Maria Valencik (University of Nevada) for the α5 integrin antibody, Allen Samarel (Stritch School of Medicine, Loyola University Chicago) for assistance with procurement of human heart specimens, and Rui Zhang (Cedars-Sinai Heart Institute), Andrea Domenighetti, Britton W. Boras, Andrew McCulloch, Ruixia Li, and Tomoko Yajima (UCSD) for excellent advice and technical assistance. This work was supported by NIH PO1 HL 46345, RO1 HL088390, and RO1 HL103566 to R.S. Ross; Eli Lilly International Fellowship, Uehara Memorial Foundation Research Fellowship, and Kanae Foundation for The Promotion of Medical Science Research Fellowship to H. Okada; NIH RO1 HL070828 to J.I. Goldhaber; NIH R01-AG014632 and the Muscular Dystrophy Association to S.J. Kaufman; and NIH R01-HL095541 to Z. Liu.
Conflict of interest: The authors have declared that no conflict of interest exists.
Citation for this article:J Clin Invest. 2013;123(10):4294–4308. doi:10.1172/JCI64216.


text:
Sponsored by: Brakes Plus
Jan 28, 2013 12:03 PM by Eric Ross
GRAND JUNCTION, Colo. (AP) - The federal Bureau of Land Management has pulled three parcels east of Dinosaur National Monument from an oil and gas lease sale after concerns were raised by the National Park Service and conservation groups.
The agency deferred the three parcels, totaling more than 5,000 acres, for further analysis.
According to the Grand Junction Daily Sentinel, environmentalists said the agency has not done a required inventory of wilderness areas around the lease parcels.
2 months ago


text:
Park in Los Angeles County, California, USA.
Latitude: 34.14139 : Longitude: -118.36417
Blogs and Websites Near Weddington Park, California - GeoURL
Weddington Park Map - Multimap
Weddington Park Street Map and Satellite Photo - Google Maps
Weddington Park Aerial Photo and Topo Map - Terraserver
Weddington Park Map - MSN
Environmental Hazards, Flood Area Maps, Boundaries - EPA
Weddington Park Area Map - MapQuest
Weather Forecast near Weddington Park - Multimap
The weather forecast links don't work for all places yet.
Some random places: Aullville Ghaaghaztail Boeer Cemetery Ugh Lake Inova Alexandria Hospital


text:
You searched for: gestational diabetes
All publications are copyright-free.
Reviewed for Plain Language Principles
All materials with this icon were reviewed by NDEP for plain language principles. Learn more about our review process.
Find Publications for Me
- hide info
To find publications specific to your search, select from the options provided below. To view more publications, select fewer options. At least one option must be selected.
Number | Title & Description | |
Did You Have Gestational Diabetes When You Were Pregnant? What You Need to Know. Women with a history of gestational diabetes have a greater chance of getting diabetes later in life. Their offspring have a greater chance of becoming obese and getting type 2 diabetes. This tip sheet encourages women who had gestational diabetes to get tested for diabetes after pregnancy and take actions to help the whole family stay healthy. Reviewed for Plain Language Principles This publication has been reviewed by NDEP for plain language principles. Learn more about our review process. Also available in these languages: Last reviewed: 04/01/2014 |


text: The Touch Controls wiki last edited by Jagged85 on 06/21/14 10:49AM View full history With touch screen platforms like the Nintendo DS, 3DS, iPhone, iPod Touch, Android, PlayStation Vita and Wii U seeing thousands of games, touch controls are becoming more and more common in portable games. With devices like the Nintendo DS, touch controls can become a part of the game along with the analog controls provided by the platform. While the Nintendo DS uses a stylus for it's main touch input, other devices like the iPhone or iPad require finger input.HistoryThe origins of the touchscreen dates back to the early 1970s. One of the earliest released touchscreens was the for the PLATO VI, which prior to the invention of the resistive touchscreen in the early 1980s, was using an infrared touch system by 1972. The touch technology used employed infrared transmitters and receivers around a flat-panel plasma screen, the first of its kind. The hardware and software were developed by the University of Illinois at Urbana-Champaign and Control Data Corporation (CDC).The first portable platform to use a touchpad pointing device was Sharp's PC-5000, one of the first laptop computers, in 1983. The use of a touchpad pointing device later become standard for laptop computers in the 1990s, especially following its use in Apple's PowerBook laptops.Sega consolesThe first attempts at introducing touchscreens to dedicated gaming systems were by Sega. As early as 1985, they released the Sega Graphic Board tablet controller for the Sega SG-1000 console in Japan. It came with a stylus pen, and the first touch-controlled game was Terebi Oekaki.They were later planning to release the first handheld game console with touchscreen controls as the intended successor to the Game Gear. Intended for release in the early-mid 1990s, the device was ultimately shelved and never released due to the expensive cost of touchscreen technology in the early 1990s.Tiger Game.comThe Tiger Game.Com, launched in 1997, was the first officially released hand held gaming system to use a touch screen. The game.com used a resistive touch screen with a stylus, and the system software was driven entirely by touch. Commercially, the system was a failure, and the idea of a touch screen gaming system was not revived until several years later.Arcade gamingJapanese arcade games have been using touch controls since the early 2000s, though these games are uncommon outside of Asia. Touch controls are used for card-based real-time strategy games, largely popularized by Sega releases such as World Club Champion Football and Sangokushi Taisen, where card placement on a touch surface corresponds to the actions of units on screen; the surface is able to identify each card separately. Arcade titles like these were the first commercially successful touchscreen games. Sega's Psy-Phi introduced full-screen HD touch controls in 2005. In more recent years, multi-touch has been used for music rhythm games, largely popularized the DJ Max Technika series from South Korea since 2008.Nintendo DSThe Nintendo DS was the first popular hand held system to feature a touch screen, and is one of the first times Nintendo had implemented a major hardware innovation since the analog stick and rumble pak used with the Nintendo 64 controller (and before that, the original light gun and D-pad controller provided with the NES console). Many games on the DS have options for touch controls, or integrate touch controls with standard physical controls. Some games, however, rely almost completely on the touch screen, such as the WarioWare series of games.iPhone/iPod/iPadUnlike the pressure-sensitive touch screen on the DS, the iDevices have a capcitive touch screen. This measures the actual electrical current in human fingers to report date from interaction. This provides for extremely accurate detection of input, even when from a finger. This technology, paired with multitouch, has allowed for games on these platforms to become closer and closer to titles one would see on a standard portable gaming device.The Trouble with TouchThe biggest roadblock to touch control based games is the complete lack of tactile response. That is, when you touch a screen, it is a completely different experience than physically pressing an analog button. Because of this, it's easy for your fingers to move from the on-screen button without you knowing it, resulting in poor gameplay and mistakes. Technology companies are currently researching "soft" touch screens that provide a certain level of physical response to touch, but it's not quite the same feel.At the launch of the App Store, many many more games tried and failed at touch controls. Some weren't smooth enough, while others simply wouldn't detect input properly. Other games had issues with being too frantic, resulting in a player having trouble keeping his fingers in the right areas of the screen. Luckily, modern games for the iPhone, particularly those from major developers, have extremely polished touch controls.UI CustomizationSome modern games for the iDevices allow the user to fully or partially change the UI of the game to suit their own preferences. Games like N.O.V.A. and Zenonia 2 allow the player to change the placement, size, and even opacity of the on-screen controls. This is especially important for a device like the iPad, which has a large screen, and can become uncomfortable without being able to rearrange the controls appropriately.This an advantage the on-screen controls have against physical buttons, as regular game controllers require extensive physical modifications to change the button layout. This idea also allows developers to design controls that tailor precisely to their own game experience. If a game only needs one button to play, the reset of the screen real estate can be used to show game content. Meanwhile, a game that requires many buttons can place them in the optical position to maximize the game experience. This can also be a disadvantage as well, as not having one controller for all games can confuse players, and require them to get used to a new control scheme with every new game they play.Touch Control LandmarksWhile there are many games out there with great touch controls nowadays, there were a few that really lead the way in creating smooth and accurate controls for touch screen games.WarioWareThese games showed us how much fun touch interaction can be in games, and relied almost 100% on touch controls.Hero of SpartaGameloft led the pack with the first successful use of a virtual joystick in this God of Waresque brawler game.Modern Combat: SandstormAgain, Gameloft innovated with the first successful FPS game on the iPhone. Using their virtual joystick in conjunction with a "swipe anywhere to aim" concept turned out to be the winning control scheme for their game, and many new FPS games to come on mobile devices.Street Fighter 4On March 10, 2010, Capcom released their famed fighting game on the iPhone and iPod Touch, and it worked. According to the lead producer of the game, Takeshi Tazuka, the team spent almost 10 months designing the fighting game controls to work well on a touch screen. The success of Street Fighter 4 on a touch screen was an important factor in bringing more major game titles to touchscreen devices in the future.N.O.V.AWhile the indie game, Bike or Die 2, was among the first to allow for full on-screen control customization, N.O.V.A. was the game that brought the idea into more widespread acceptance. By allowing the player to completely reposition and resize the virtual buttons and joysticks as they saw fit, it allowed them to play the game however was most comfortable for them. Since then, many games with UI customizing options have been released.


text: A nautical bedding collection, with images of sea shells, coral and sea horses, in shades of blue, rust and slate blue on an ivory cream ground, the Historie De La Mer Bedding by C & F Bedding will transform your bedroom into an ocean inspired beach cottage retreat. áHistorie De La Mer, which in French means ôHistory of the Seaö, lives up to its name as this bed set is a colorful illustration of sea life. Available in Twin, Queen and King sizes, the C & F Historie De La Mer quilt collection features an intricate design of seaweed, coral, sea horses, scallops and conch shells in a palette of blue and brown hues, on a sand ground, embellished with vermicelli stitching and scalloped edging.


text:
Second Cancers Caused by Cancer Treatment
Childhood cancers
As treatment for childhood cancer has improved and more children are surviving into adulthood, researchers have learned that the effects of treatment may affect the child's health later in life. This result, known as a "late effect," often includes an increased risk for some types of cancer. For more information about this topic, see our document, Childhood Cancer: Late Effects of Cancer Treatment. If you'd like this information, please call our 24-hour number 1-800-227-2345, or search for it on our Web site at www.cancer.org.
Last Medical Review: 01/30/2012
Last Revised: 01/30/2012


text:
The Jockey Club to Help Fund Racehorse Drug Testing
August 12, 2013
The Jockey Club will provide funds to some racing jurisdictions to step up out-of-competition drug testing. ... Read More
BHA Investigation into Drug 'Sungate' Concludes
August 08, 2013
The BHA concluded its investigation into "Sungate," a veterinary product which contains an anabolic steroid. ... Read More
Owners Again Support Medication-Free Horse Racing
August 05, 2013
Many of horse racing's top owners again pledged to race their 2-year-olds without race-day medication. ... Read More
RCI Approves Model Rule for Racehorse Drug Penalties
July 31, 2013
RCI voted to approve model rules that create a points system and enhanced penalties for drug violations. ... Read More
RMTC: Confidentiality in Research Necessary
July 26, 2013
An official explains why confidentiality is used when setting medication thresholds and withdrawal times.... Read More
Kentucky Racing Officials: New Drug Policy Is Working
July 25, 2013
Regulatory administration of race-day anti-bleeding medication has provided a clearer picture of drug testing.... Read More
Kentucky Approves 'Rapid Response' Protocol
July 22, 2013
The Kentucky Horse Racing Commission approved a "rapid response" protocol to examine emerging illegal drugs.... Read More
RMTC Approves Multiple Violation Penalty Model Rule
July 19, 2013
The model rule represents a plan to provide appropriate penalties for violations of medication regulations.... Read More
What's in Your Horse's Urine Sample?
July 18, 2013
Do you know for sure that your horse would pass a random horse show drug test? ... Read More
Foreman: Racehorse Drug Model Rule a 'Living Document'
July 16, 2013
The regulations are a "living document" that likely will be adjusted based on industry needs, one group says.... Read More
Scientists Question Clenbuterol Regulations for Racehorses
July 15, 2013
Some veterinarians expressed concerns over the proposed clenbuterol withdrawal time and testing levels.... Read More
Stiff Penalties Tied to Drugs 'Purple Pain,' 'TB-500'
July 03, 2013
The drugs, only available through compounding pharmacies, will be high-level violations if used in racing.... Read More
FDA Approval Significance
June 27, 2013
Dr. Megan Green, Merial field veterinarian, describes how horse owners can determine if a drug is approved. ... Read More
Kentucky Protocol Would Target Emerging Drugs
June 13, 2013
The measures would allow the state to take action quickly when faced with emerging illegal substances. ... Read More
Racehorse Trainer Butler Faces Charges for Steroid Use
June 07, 2013
A British racehorse trainer has been charged with administering anabolic steroids to nine of his racehorses.... Read More
Progress Cited on Racehorse Medication Penalty System
June 07, 2013
Plans to implement a points-driven penalty system for equine medication violations are moving forward. ... Read More
Progress of Uniform Racehorse Medication Policy Noted
June 06, 2013
Survey results show the adoption of RCI's uniform medication policy for racing is advancing nationwide.... Read More
Another British Racehorse Trainer to Face Steroid Charges
June 04, 2013
Gerard Butler will be charged for using the drug Sungate, which contains the anabolic steroid stanozolol. ... Read More
Study: Salix Administration Can Lead to Calcium Imbalance
June 01, 2013
Horses receiving Salix had difficulty replenishing their calcium levels 72 hours after drug administration.... Read More
TOC Commits to Uniform Racehorse Medication Program
May 24, 2013
TOC has committed to implement the Mid-Atlantic Uniform Medication Program beginning in January 2014.... Read More
Enhanced Security Measures for Belmont Stakes Horses
May 22, 2013
Security measures include the submission and publication of veterinary records for Belmont Stakes horses. ... Read More
New Federal Racehorse Drug Legislation Introduced
May 20, 2013
The new legislation would regulate/prohibit substances, methods, and treatments that can be used in racing. ... Read More
Still No Uniform Racehorse Medication Rules in Triple Crown
May 17, 2013
While horse racing has made strides toward drug reform and uniform medication rules, inconsistencies remain.... Read More
Medications in Horse Racing
May 03, 2013
Dr. Larry Bramlage shares his thoughts on recent and upcoming topics in racehorse medications.... Read More
Careful Drug Use Helps Prevent Antimicrobial Resistance
May 03, 2013
Though routinely discussed in human medicine, antibiotic resistance is becoming an issue in the equine world.... Read More
Related Topics
Related Multimedia & Downloads
Farm Call: Your Questions Answered
Can Horses Take Firocoxib Long-Term?
Q. My horse receives 25 milligrams of Previcox daily to manage pain related to navicular syndrome. Is long-term use of this drug okay?


text:
Lukas Ligeti is the son of György Ligeti, one of the most influential composers of the Twentieth Century and a pioneer in "nonpurist music," which incorporates sounds not traditionally believed to be "musical." The senior Ligeti, an exile from the communist regime that ruled Hungary from 1949 through 1989, fled to Austria in 1956. Since then he has composed landmark experimental works performed by orchestras throughout the world. To the moviegoing masses of the United States, however, he probably is best known for the excerpts from his 1961 work Atmospheres and 1965's Requiem, heard in the soundtrack to Stanley Kubrick's 1968 science-fiction classic 2001: A Space Odyssey. In Atmospheres Ligeti introduced the dense layers of sound he calls "chromatic clusters," and the rhythmically complex canons he calls "micropolyphony."
Growing up in a household where chromatic clusters and micropolyphony sounded as familiar as nursery rhymes, Lukas Ligeti was exposed to experimental music at a very early age. Awed by his father's artistry, however, he shied away from music and cultivated a frivolous youth while attending American-style international schools in Vienna. "I never learned to play an instrument in my father's house," he recalls. Not until after high school graduation did he take a crash course in piano so he could apply to the Vienna Music Academy. "I realized when I was seventeen," he says, "that I always had a soundtrack in my head. So I thought I might as well be a composer. Besides, I thought if my father could be a composer, then I could, too."
In 1983 Ligeti entered the music academy as "an absolute beginner" in what he believed would be the easiest program, classical drumming. Two years later he switched to the eight-year composition program. After completing his studies in 1993, he composed Groove Magic, a twenty-minute work for eleven musicians that premiered with the London Sinfonietta. His first composition based on click tracks, Groove Magic remains to this date his "flashy, big-guy" orchestral piece. "It's such a crazy thing to do," he laughs, "that I don't think anyone but me has ever done it before or since."
In February 1994 the Goethe Institute, which promotes German culture abroad, sent Ligeti and another musician to the music conservatory in Abidjan, the capital of the Ivory Coast, to conduct a two-week workshop on drumming and electronic music. There Ligeti used electronics to establish what he calls a "third plateau," a musical no-man's land where the Africans and the Europeans could create a new language in electro-sonic space. Over the past six years, the two Europeans have returned often to the Ivory Coast to work in what has become a professional ensemble of fourteen musicians called Beta Foly. In Malinké, a language spoken by many ethnic groups in and around the West African nation, the band's name means "the music of all of us." Each Beta Foly composition, says Ligeti, contains elements that would not have been possible without the cultural experience of every member. The click-track songs he composed for Beta Foly go beyond even the European and West African cultures of the band members to introduce elements from East Africa and Asia as well.
Ligeti knows firsthand the pitfalls of superficial attempts at cultural exchange. In March 1995 he traveled with a delegation of Austrian composers to the village of Siachilaba in Zimbabwe, just south of the Zambian border, on a monthlong project with the Tonga, a Bantu-speaking people whose complex arrangements have so bewildered ethnomusicologists that one scholar could provide no more precise description for what he heard than "raucous noise." "They have this funeral music called ngoma bontibe," explains Ligeti, "that groups of ten to twenty men play on eight different sizes of antelope horns. I have no idea how they do the arrangement. I could stand next to somebody and repeat his phrase after him, but I could not find the beat that held the phrases together."
With no translators in the group, Ligeti's music struck the Tonga as equally mysterious. He unpacked his gear in the Siachilaba beer hall just one month after electrification came to the village for the first time. With refrigerators, electric lights, and the radio still a novelty, roughly 200 youngsters crammed into the hall one afternoon to listen to him play an electronic drum. "I set up my stuff and the kids got very intense," he recalls. "When I was done, they didn't know if I was finished or not, so they just kept sitting there, listening." He laughs. "I think they were the best audience I ever had."
Meaningful cultural exchange for Ligeti means recognizing musical differences, then using those differences to create a common language. "I don't believe in roots," he declares. "I have no interest in preservation. People say it's dangerous to mix this European thing with this African thing. For me that's not a problem. What's a problem is for musicians not to have a language to communicate with each other and with their audiences. [Here in Miami] I want to use elements of a vocabulary, taken from everyone, that I can somehow understand and put together in a composition. Yes, I will be taking things out of context. But we will be putting them into a new context so that we can understand each other."